DEF: PROCEPT BioRobotics Sets Date for 2025 Annual Stockholders Meeting

PROCEPT BioRobotics Corporation will hold its 2025 annual meeting of stockholders virtually on June 10, 2025, to elect directors, ratify the selection of its accounting firm, and approve executive compensation.

Summary

• PROCEPT BioRobotics Corporation will hold its annual meeting of stockholders on June 10, 2025, in a virtual format.
• Stockholders of record as of April 11, 2025, are eligible to vote.
• The meeting will address the election of three Class I directors (Elisabeth Little, Thomas M. Prescott, and Larry Wood) to serve until the 2028 annual meeting.
• Stockholders will also vote to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• An advisory vote on the compensation of the company's named executive officers (NEOs) will also take place.
• The Board of Directors recommends voting for the election of the director nominees, for the ratification of PwC, and for the approval of the NEO compensation.
• The company's common stock outstanding and entitled to vote as of April 11, 2025, was 55,318,654 shares.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment due to the routine nature of the information and the company's adherence to corporate governance practices.

Positives

• The company is embracing technology by hosting a virtual meeting to provide expanded access, improved communication, and cost savings for stockholders.
• The Board of Directors is recommending a vote in favor of all proposals.
• The company has a clawback policy in place to recover incentive compensation from NEOs in the event of an accounting restatement.

Future Outlook

The Board and Compensation Committee will consider the outcome of the advisory vote on executive compensation when making future decisions regarding executive compensation.

Management Comments

• We are excited to embrace the latest technology to provide expanded access, improved communication and cost savings for our stockholders and the Company, and to reduce the environmental impact of paper proxies.
• We believe that hosting a virtual meeting was a positive experience for our prior meeting.

Industry Context

This announcement is a routine part of corporate governance for publicly traded companies, ensuring stockholders have a voice in key decisions.

Comparison to Industry Standards

• The company's virtual annual meeting aligns with a growing trend among public companies to leverage technology for increased accessibility and cost efficiency, similar to companies like Align Technology and Edwards Lifesciences.
• The director compensation program, including cash retainers and equity awards, is structured to be competitive with peer companies in the medical device and life sciences sectors, such as AtriCure, Axonics, and Glaukos Corporation.
• The company's commitment to ESG matters and the publication of a report on these topics is in line with increasing investor expectations for corporate responsibility, similar to practices at Baxter International and CTS Corporation.

Related Party Transactions

• The company is party to an amended and restated investor rights agreement with certain holders of its common stock, including entities affiliated with certain executive officers and directors.

Stakeholder Impact

• Stockholders have the opportunity to vote on key company matters.
• The election of directors will shape the company's leadership and strategic direction.
• The advisory vote on executive compensation allows stockholders to express their views on pay practices.

Next Steps

• Stockholders are encouraged to vote by proxy before the meeting.
• Stockholders can attend the virtual Annual Meeting on June 10, 2025.
• The company will file the final voting results with the SEC within four business days after the Annual Meeting.

Key Dates

Keywords

annual meeting, proxy statement, directors, executive compensation, PricewaterhouseCoopers, stockholders, corporate governance, PROCEPT BioRobotics